Merck & Co. Inc. (MRK)
NYSE: MRK
· Real-Time Price · USD
84.44
1.68 (2.03%)
At close: Aug 15, 2025, 3:42 PM
Merck & Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 5.08B | 3.74B | 3.16B | 5.46B | 4.77B | -1.23B | 4.75B | -5.97B | 2.82B | 3.02B | 3.25B | 3.95B | 4.31B | 3.82B | 4.57B | 777M | 2.75B |
Depreciation & Amortization | 1.1B | 1.2B | 1.19B | 1.13B | 984M | 964M | 1.01B | 903M | 991M | 892M | 959M | 938M | 1.12B | 835M | 759M | 690M | 892M |
Stock-Based Compensation | 195M | 187M | 195M | 203M | 176M | 167M | 164M | 169M | 145M | 145M | 139M | 137M | 120M | 119M | 117M | 132M | 111M |
Other Working Capital | n/a | -1.85B | 2.58B | -1.01B | -3.38B | 144M | 2.18B | -1.64B | -2.89B | 417M | 263M | -1.4B | -1.3B | -45M | -139M | -1.55B | -2.19B |
Other Non-Cash Items | -3.69B | 793M | 2.57B | 34M | 596M | 1.13B | -47M | 10.6B | 549M | 1.03B | 1.65B | 939M | 851M | 139M | -510M | 2.41B | 213M |
Deferred Income Tax | -186M | -616M | -401M | -181M | -51M | -931M | -336M | -355M | -277M | -307M | -661M | -262M | -338M | 159M | -1M | 39M | 18M |
Change in Working Capital | n/a | -1.85B | 2.58B | -1.01B | -3.38B | 144M | 2.18B | -1.64B | -2.89B | -347M | 263M | -1.4B | -1.3B | -45M | -139M | -1.55B | -2.19B |
Operating Cash Flow | 2.5B | 3.45B | 9.29B | 5.64B | 3.09B | 246M | 7.72B | 3.7B | 1.34B | 4.43B | 5.6B | 4.3B | 4.76B | 5.03B | 4.8B | 2.49B | 1.79B |
Capital Expenditures | -1.33B | -937M | -783M | -791M | -861M | -989M | -902M | -965M | -1.01B | -1.15B | -1.13B | -1.13B | -984M | -1.21B | -1.17B | -934M | -1.13B |
Cash Acquisitions | n/a | -2M | -3.35B | n/a | -746M | n/a | 902M | -10.71B | -1.33B | n/a | -121M | n/a | n/a | -11.26B | 1M | -1.63B | -14M |
Purchase of Investments | -685M | -455M | n/a | -49M | -15M | -251M | -117M | -25M | -562M | -494M | -5M | -333M | -372M | n/a | 1.17B | n/a | -1M |
Sales Maturities Of Investments | 456M | 7M | 50M | 60M | 260M | 169M | 704M | 285M | 500M | 12M | 335M | 373M | 1M | 529M | 111M | n/a | 386M |
Other Investing Acitivies | 70M | -57M | 233M | -289M | -14M | 1.12B | -921M | -33M | 37M | -117M | -45M | 12M | 182M | -106M | -1.17B | -143M | 25M |
Investing Cash Flow | -1.49B | -1.44B | -3.85B | -1.07B | -1.38B | 53M | -334M | -11.44B | -2.36B | -1.75B | -962M | -1.08B | -1.17B | -12.05B | -1.06B | -2.71B | -738M |
Debt Repayment | n/a | -539M | -1M | 3.6B | -751M | -3M | -1.95B | 6.13B | -1M | -1M | -1B | n/a | -1.25B | 6.77B | n/a | -4.77B | -365M |
Common Stock Repurchased | -1.16B | -489M | -444M | -251M | -122M | -393M | -466M | -338M | -149M | -265M | -10M | n/a | n/a | -18M | -583M | -239M | n/a |
Dividend Paid | -2.05B | -1.95B | -1.95B | -1.99B | -1.95B | -1.85B | -1.85B | -1.89B | -1.85B | -1.75B | -1.75B | -1.77B | -1.75B | -1.64B | -1.65B | -1.67B | -1.65B |
Other Financial Acitivies | -2.56B | -30M | -27M | -147M | 9M | 3M | -3M | -152M | -51M | 197M | 45M | -104M | -91M | 101M | -42M | 8.44B | -88M |
Financial Cash Flow | -5.75B | -3.01B | -2.42B | 1.22B | -2.81B | -2.25B | -4.27B | 3.76B | -2.05B | -1.55B | -2.7B | -1.78B | -3.09B | 5.21B | -2.27B | 1.76B | -2.1B |
Net Cash Flow | -4.59B | -1.37B | 3.31B | 5.7B | -1.24B | -1.76B | 2.96B | -4.07B | -2.99B | 1.49B | 1.53B | 1.14B | 447M | -1.88B | 1.42B | 1.59B | -1.14B |
Free Cash Flow | 1.17B | 2.51B | 8.51B | 4.85B | 2.23B | -743M | 6.82B | 2.74B | 332M | 3.28B | 4.48B | 3.17B | 3.78B | 3.82B | 3.63B | 1.56B | 657M |